The patient must: Be age 18 or older Have eligible Medicare Part D coverage Be prescribed treatment specifically for weight reduction and maintenance Participate in ongoing nutrition and physical activity intervention Not have already received a GLP-1 through their Part D plan Not be seeking coverage for another Part D-coverable indication, such as type 2 diabetes, moderate-to-severe obstructive sleep apnea, MASH, or cardiovascular risk reduction The patient must also have met one of these criteria when GLP-1 therapy was originally started: BMI 35 BMI 30 plus HFpEF, uncontrolled hypertension despite 2 medications, or CKD stage 3a+ BMI 27 plus prediabetes, prior MI, prior stroke, or symptomatic peripheral artery disease Important: Eligibility is based on BMI at treatment initiation, not necessarily the patients current BMI
Why Am I Not Losing Weight on GLP-1 medication For individuals utilizing GLP-1 medication as part of their weight loss journey, the question of why the desired results may be elusive is a common concern
Both your skin and your gut harbor microbial ecosystems that directly shape the compounds your body releases into sweat and breath
the published evidence is three separate single-compound literatures
Additionally, DMD and HD exhibited relatively high proportions of DHT uptake (Fig
GLP-1 encourages the development of various advantageous bacteria in the gut, making it easier to produce satiety-related microbial products
